OncoZenge: SEK7.5m convertible loan agreement with Linc - Redeye
Bildkälla: Stockfoto

OncoZenge: SEK7.5m convertible loan agreement with Linc - Redeye

Redeye comments on OncoZenge’s announcement of a SEK7.5m convertible loan agreement with major shareholder Linc. We view this as a strategic move that enhances the company’s financial flexibility ahead of the pivotal phase III trial for BupiZenge, further reinforcing recent momentum in funding and partnership execution.

Redeye comments on OncoZenge’s announcement of a SEK7.5m convertible loan agreement with major shareholder Linc. We view this as a strategic move that enhances the company’s financial flexibility ahead of the pivotal phase III trial for BupiZenge, further reinforcing recent momentum in funding and partnership execution.
Börsvärldens nyhetsbrev